Cooper and Mitelos will make available a new product to prevent external otitis
Agreement between Laboratoire Cooper and Mitelos to market Audispray Dry in France (including DROM COM and Monaco), and Italy.
Audispray Dry helps prevent acute external otitis, also known as “swimmer’s ear”. This pathology consists of an infection, normally of bacterial origin, of the skin in the external auditory canal. The main triggering factor is moisture excess (due to daily hygiene, water sports, very humid environments or climates, excessive sweating, etc.), which can often be aggravated with concomitant small wounds to the ear canal caused by scratching or manipulation with foreign objects. External otitis can be painful and can manifest as inflammation of the external ear canal, drainage, itching, low-grade fever, etc.
The ingredients of Audispray Dry facilitate drying of excess moisture, allow the recovery of the physiological pH and protect the skin from the external ear canal; all these three properties contributing to preventing infection.
This is the first agreement between our companies that adds a new product to Cooper’s ear care range. Ear care is a strategic area for Cooper, with significant commercial activity.
Ear care is essential to avoid hearing problems and infections. Acute external otitis is one of the main reasons for consultation in both primary care and ENT emergencies.
Audispray Dry is available in pharmacies and parapharmacies. It comes in a 30 mL bottle, including the ergonomic push button ear spray, which allows for convenient administration. Audispray Dry does not require a prescription.